Ferrous sulfate


Generic Medicine Info
Administration
Should be taken on an empty stomach. Best taken on an empty stomach. May be taken w/ meals to reduce GI discomfort.
Contraindications
Haemochromatosis, other iron overload syndromes. Blood disorders (e.g. paroxysmal nocturnal haemoglobinuria, haemolytic anaemia, haemosiderosis, other anaemias); active peptic ulcer, regional enteritis and ulcerative colitis. Patient receiving frequent blood transfusions. Concomitant parenteral iron therapy.
Special Precautions
Patient with haemoglobinopathies, iron storage or iron absorption diseases, existing gastrointestinal disease, history of peptic ulcer, intestinal strictures or diverticula. Children and elderly. Pregnancy and lactation. Monitoring Parameters Monitor Hb and haematocrit; RBC count and indices, serum ferritin, transferrin saturation, total iron-binding capacity, serum iron concentration and erythrocyte protoporphyrin concentration.
Adverse Reactions
Gastrointestinal disorders: Gastrointestinal irritation, nausea, vomiting, epigastric pain, diarrhoea, constipation, blackening of stool, tooth discolouration, abdominal discomfort. Immune system disorders: Hypersensitivity.
Drug Interactions
May decrease the absorption of tetracyclines, fluoroquinolones (e.g. ciprofloxacin, norfloxacin, ofloxacin), bisphosphonates, levodopa, methyldopa, penicillamine, entacapone and levothyroxine. Reduced absorption with antacids, products containing zinc, magnesium, calcium, phosphorus, and trientine. Colestyramine binds iron to the gastrointestinal tract thus preventing its absorption. Delayed plasma clearance with chloramphenicol.
ATC Classification
B03AA07 - ferrous sulfate ; Belongs to the class of oral iron bivalent preparations. Used in the treatment of anemia.
B03AD03 - ferrous sulfate ; Belongs to the class of iron in combination with folic acid. Used in the treatment of anemia.
Disclaimer: This information is independently developed by CIMS based on ferrous sulfate from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in